UW Center for Dialysis Innovation gets $15M grant to improve … – GeekWire

Jonathan Himmelfarb, co-director of the UWs Center for Dialysis Innovation and also director of the UWs Kidney Research Institute. (UW Photo)

Dialysis can be a life-saving treatment forthe millions of people across the globe who face kidney failure. But despite the importance of this treatment, the technology behind it is still essentially the same as when the process was pioneered at the University of Washington in Seattle in the early 60s.

Now, a new UW center is hoping to revolutionize the technology again. The Center for Dialysis Innovation brings together researchers from around the university with the goal of greatly improving dialysis technology, and it just received a $15 million grant from nonprofit dialysis providerNorthwest Kidney Centers to pursue that goal.

Northwest Kidney Centers says the grant will support startup projects within the Center for Dialysis Innovation, with the goal of one day developing dialysis technology that can completely restore kidney health.

Dialysis is currently the only treatment for kidney failure, short of a kidney transplant. Today, over 450,000 people in the U.S. are on dialysis, and the life expectancy for those patients is only 3 to 5 years.

We are excited about the Center for Dialysis Innovation because it brings together creative, entrepreneurial, can-do minds from a wide range of fields including nephrology and bioengineering. This team also wants to involve people living with kidney disease to help direct the centers focus, said Joyce Jackson, CEO of Northwest Kidney Centers, said in a pressrelease.

Their aim is to develop revolutionary dialysis technologies, including a wearable dialysis system that is low-cost, and energy- and water-efficient. This would not only sustain users lives, but give them more vitality and productivity. This work is desperately needed, she said.

The $15 million will be delivered to the center over the next five years. It is the first outside funding the center has receivedand makes up over half of its goal budget of $25 million.

The Center for Dialysis Innovation opened last Novemberand brings together researchers from the UWsKidney Research Institute and the universitys department of biomaterials and bioengineering. It is led by co-directors Jonathan Himmelfarb, director of the UWs Kidney Research Institute, and Buddy Ratner, a professor of bioengineering and chemical engineering.

See the rest here:
UW Center for Dialysis Innovation gets $15M grant to improve ... - GeekWire

Team Develops More Effective Therapeutic Antibodies – Genetic Engineering & Biotechnology News

Researchers from the University of Maryland and Rockefeller University, who previously developed a method to modify an antibody's sugar group structure, which opened the door for biochemists to create antibodies with consistent sugar groups, report that they havetaken their method a step further by determining which specific sugar combinations enhance--or suppress--an antibody's ability to signal the immune system to attack an invader.

The results ("Modulating IgG effector function by Fc glycan engineering"),published online in theProceedings of the National Academy of Sciences, are an important step toward the development of highly effective antibodies to fight cancer and other diseases, according to the investigators.

An antibody's ability to send killer signals depends on the configuration of sugar chains attached to the protein. In naturally occurring antibodies, these sugar chains have a lot of variability. Even in antibodies currently used for disease therapy, a given dose might contain a wide variety of antibody variants, also known as "glycoforms," distinguished by their sugar groups.

Although prior methods tried to sort out these glycoforms and collect the most effective ones, these methods are time-consuming, expensive and not 100 percent effective. The method used in the current study enables the researchers to create a given antibody with identical glycoforms using biochemical techniques. Each glycoform can then be tested independently to see whether it enhances or suppresses the immune response.

"Our first major step forward was to develop a method to produce homogeneous glycoforms," said Lai-Xi Wang, Ph.D., a professor of chemistry and biochemistry at UMD. "With this, we can now look at how individual different sugars affect the properties of antibodies. Until this study, we didn't have an efficient way to know how individual sugars in various glycoforms affect suppression or activation of the immune response."

Most therapeutic antibodies on the market are designed to treat cancer and autoimmune diseases. For example, Rituximab is an antibody-based drug used to treat lymphoma, leukemia and rheumatoid arthritis. Rituximab and other similar antibody drugs are usually produced in cultured cell lines.

"These processes are not optimized at all. There is no easy way to control glycosylation," noted Dr. Wang. Glycosylation is the process by which sugar groups are added to a protein such as an antibody. "Our method could be used to improve antibodies already on the market because it modifies the antibodies directly instead of working at the genetic level."

Dr. Wang's group, which specializes in the biochemistry of protein glycosylation, developed the methodology to modify the antibody sugar groups. They partnered with Jeffrey Ravetch's group at Rockefeller University, which specializes in immunology and animal models, to test the effects of various glycoforms on the immune response. The new findings will help guide the development of future antibody-based therapeutics.

"Our method would be generally applicable because it can be used on a wide variety of antibodies," explained Dr. Wang. "It's an important step forward in the effort to engineer therapeutic antibodies that can target specific cancers, inflammation and other diseases. Soon we will be able to build customized antibodies."

View post:
Team Develops More Effective Therapeutic Antibodies - Genetic Engineering & Biotechnology News

Scoop: GREY’S ANATOMY on ABC – Thursday, March 30, 2017 – Broadway World

In the episode Be Still, My Soul, when Maggies moms health deteriorates, the doctors are at odds over how to treat her. Meanwhile, Richard comes to grips with Baileys betrayal over the Residency Program, on Greys Anatomy, THURSDAY, MARCH 30 (8:00-9:01 p.m. EDT), on The ABC Television Network.

Greys Anatomy stars Ellen Pompeo as Meredith Grey, Justin Chambers as Alex Karev, Chandra Wilson as Miranda Bailey, James Pickens Jr. as Richard Webber, Kevin McKidd as Owen Hunt, Jessica Capshaw as Arizona Robbins, Jesse Williams as Jackson Avery, Sarah Drew as April Kepner, Caterina Scorsone as Amelia Shepherd, Camilla Luddington as Jo Wilson, Jerrika Hinton as Stephanie Edwards, Kelly McCreary as Maggie Pierce, Jason George as Ben Warren, Martin Henderson as Nathan Riggs and Giacomo Gianniotti as Andrew DeLuca.

Greys Anatomy was created and is executive produced by Shonda Rhimes (Scandal, How to Get Away with Murder), Betsy Beers (Scandal, How to Get Away with Murder) and Mark Gordon (Saving Private Ryan). William Harper, Stacy McKee, Zoanne Clack and Debbie Allen are executive producers. Greys Anatomy is produced by ABC Studios.

Guest Starring is Marika Dominczyk as Eliza Minnick, LaTanya Richardson Jackson as Diane Pierce and Richard Lawson as Bill Pierce.

Be Still, My Soul was written by Meg Marinis and directed by Ellen Pompeo.

Greys Anatomy is broadcasted in 720 Progressive (720P), ABCs selected HTV format, with 5.1-channel surround sound.

The rest is here:
Scoop: GREY'S ANATOMY on ABC - Thursday, March 30, 2017 - Broadway World

Health Benefits of Lion’s Mane Mushroom – Anti Aging News

Health Benefits of Lion's Mane Mushroom

The Chinese have used Lions Mane Mushroom as a medicine for centuries. Many communities in Asia have used it as food. The Chinese and Japanese call it hou tou gu and yamabushitake respectively. It derives its name from a distinctive appearance that makes it resemble the mane of a shaggy lion. Apart from its appearance, origins, use as food and local names, the Lions Mane Mushroom has several health benefits too.

Boosts Digestive Health

The plant proved highly useful in promoting digestive health. It enables the stomach and liver to function properly. It also protects the liver. It is effective at treating chronic gastric inflammation, duodenal ulcers, and peptic ulcers. Many patients have used it in alleviating mental apathy (also known as neurasthenia). Its usage as a restorative health tonic has also borne good fruits.

Useful as a Dietary Supplement

Today, the mushroom continues to prove its efficiency in clinical use. Physicians recommend it as a dietary supplement. The reason for this is the positive effect that it has on mood, brain health, and memory. Scientific studies have proved that the mushroom is capable of increasing neurotrophic activities. It stimulates the growth of nerve or brain cells, thus boosting neurotrophic activities. This effect enhances its reputation as a brain strengthener and antidepressant. Facilitates the Production of Nerve Growth Factor

The mushroom has bioactives, which are called hericenones (or aromatic molecules). These bioactives, including erinacines (or diterpene compounds), collaborate to boost the production of Nerve Growth Factor (NGF) in nerve cells. By doing this, the mushroom maintains forebrain function and cholinergic system. So, the mushroom plays a role in the proper maintenance of the central nervous system. Remember, the forebrain is important because of the following:

Reduces Bad Cholesterol and Increases Good Cholesterol

Other than medicinal uses, Lions Mane Mushroom is also renowned as a cholesterol reducer. A unique, submerged culture of the mushroom reduces cholesterol by around 32%. The same culture reduces LDL cholesterol by around 45.4%. It also reduces triglycerides by as much as 34.3 percent. More importantly, it increases HDL cholesterol, which is the good cholesterol, by around 31%. So, it eradicates the bad while boosting the good cholesterol.

Provides Perfect Immune Support

Additionally, it offers immune support. It increases the ability of the host (whether animals or humans) to resist infection. The mushroom enhances the uptake of bacteria by white blood cells. The immune booster increases the ability of macrophage cells to engulf the harmful bacteria before destroying them. Treating cell culture with an extract of Lions Mane Mushroom allows the cells to display greater movement against the bacteria rather than controlling them. The other health benefits of Lions Mane Mushroom include:

Theres little doubt about the effectiveness of the mushroom extract. Its health benefits make it one of the most exciting nutraceuticals. It has been tested on humans and found effective at enhancing memory and improving moods. However, most of its health benefits have so far been displayed in animals and test tube results. The mushroom needs to undergo further testing on humans its precise efficacy levels and the recommended dosages.

Read more from the original source:
Health Benefits of Lion's Mane Mushroom - Anti Aging News

Microbiology Testing Market Players Johnson & Johnson, Bruker Corporation, Cepheid, Danaher Corporation and … – MENAFN.COM

MENAFN Press - 12/03/2017 (MENAFN Editorial) Microbiology testing Application: Microbiology testing is majorly used in pharmaceuticals/medical, food and beverages market, energy and in cosmetics market. The products such as Aqua Plate, Real-time PCR, food pathogen system, etc. are being used by laboratories to test water contamination, pharmaceuticals and food samples. Various methods such as culture testing method or food pathogen test are used to perform microbial testing on the microbial samples.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/697

Key Players: Abbott Laboratories Inc. (U.S.) Alere, Inc. (U.S.) bioMrieux SA (France) Becton Bio-Rad Laboratories Bruker Corporation (U.S.) Cepheid (U.S.) Danaher Corporation (U.S.) Hologic Hoffmann-La Roche Ltd. (Switzerland)

Regional Analysis North America North America dominates the Microbiology Tests Market due to large number of market-focused players providing wider range of product portfolio and is followed by Europe. Asia Emerging economies of Asia Pacific and Latin America are expected to show significant growth in the microbiology tests market due to an increase in the number of laboratories in these regions and development of existing ones for automation of various instrumentation systems.

About Microbiology Testing Market: This is very essential to ensure the safety of products people eat and drink or use in their daily routine. The FDA sets scientific standards for testing foods for various contaminants. Laboratories and food companies worldwide use these standards to make sure that food products are safe to eat and drink. The Microbial testing is one of these methods used for the purpose of testing.

Segmentation By Application - Food, Energy, Pharmaceutical, Clinic By Consumable - Kit and Reagent By Instruments - Dispenser, Automated microbiology By Regio- North America, Asia-Pacific, Europe and Row

Access full MT market @ https://www.marketresearchfuture.com/reports/microbiology-testing-market

Taste the market data and market information presented through more than 150 market data tables and figures spread in 115 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on 'Microbiology testing market Research Report- Global Forecast to 2024'

Microbiology Testing Market Growth Influencer: The major growth drivers of microbial market is the large disease burden of infectious diseases, the growing trend of laboratory automation, the increase in access to medical insurance and increased healthcare expenditure. However, strict regulatory policies for medical devices, advancements in molecular diagnostic technologies, reimbursement issues are the major restraints of microbiology market.

Geographical Region Includes Americas North America US Canada Europe Western Europe Germany France Italy Spain U.K Rest of Western Europe Eastern Europe Poland Russia Asia Pacific Asia China India Japan Rest of Asia Pacific Countries Australia New Zealand The Middle East & Africa

About Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact: Akash Anand Market Research Future Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India 1 646 845 9312 Email: Web: https://www.marketresearchfuture.com

MENAFN1203201700703196ID1095306940

About EIN EIN Presswire publishes and distributes press releases worldwide for small and mid-sized companies both public and private. Specializing in industry and business, topic categories range from agriculture and aviation to pharma and technology. The company was founded in 1995.

View original post here:
Microbiology Testing Market Players Johnson & Johnson, Bruker Corporation, Cepheid, Danaher Corporation and ... - MENAFN.COM

The Role of Small Species in Genetic Modification, at UNCW – WHQR

Listen to this story here

Most of us know very little about the organisms in our own backyard, bedroom, roommate or even on our bodies. Rob Dunn, a Professor of Applied Ecology at North Carolina State University, will try to change that when he speaks tomorrow night at UNCW.

Professor Dunns work focuses on ecology and evolution, with a keen interest on the small species that live all around us and the role they play in the world.

One is the extent to which everything about how our bodies work is really contingent on all the species that live in and on our bodies.

In addition, Dunn will discuss how in the age of genetically-modified crops and foods, nature and what lives in the wild still have a large role to play.

And so you might imagine that if you can genetically-engineer all kinds of new crops that you dont need wild nature anymore, but it turns out that most of our tricks for engineering those crops come from new genes that we found somewhere in the wild.

Also on Wednesday Dunn will be unveiling his new book, titled Never Out of Season.

The lecture will be followed by a question and answer session and book-signing.

Professor Dunns talk is at 7 p.m., this Wednesday, in the Warwick Ballroom at UNCW.

Go here to read the rest:
The Role of Small Species in Genetic Modification, at UNCW - WHQR

Genetic Engineering – Hutchinson News

MANHATTAN Richard Dick Janssen of Ellsworth was named the 2017 Kansas Stockman of the Year during the 47th annual Stockmens Dinner in Manhattan.

Industry friends recognized Janssen for his contributions to the beef industry, and speakers described him as a visionary and an accomplished cattleman.

He is one of the most courageous and daring genetic engineers on the planet, said fellow Angus breeder Mary Ferguson.

Dan Moser, president of Angus Genetics Inc., said Janssen is making the investment in new technology and seeing the benefits and costs with his own eyes, with his own cattle and his own checkbook. Dick has positioned his business and those of his customers to take maximum benefit of these new tools.

Janssen started raising and showing his own Angus cattle in 4-H when he was 11, and hes been involved in the registered Angus business ever since. A 1964 graduate of Kansas State University with a degree in animal science, Janssen returned home and joined in a partnership with his brother, Arlo.

They farmed 1,200 acres of wheat, milo and alfalfa and managed their Angus herd. They also custom-fit and showed cattle nationwide. In 1969, Arlo transitioned to fitting and showing cattle full-time while Richard stayed in Kansas to manage his division of Green Garden Angus and farming.

In 1974, he married Shelly and they continued to expand their cattle operation, which now has 350 head. The couple had two children, Ben and Elizabeth.

In 1989, John Brethour, beef cattle scientist at K-States Ag Research Center-Hays, used the Green Garden herd to perfect ultrasound measurements of cattle.

In 2000, they were one of the first herds to use GeneStar DNA mapping and today they are using 50K DNA testing for yearling bulls and heifers.

In 2010, the Janssens sent their bulls to Hays Development Center in Diagonal, Iowa, to be evaluated for average daily gain, dry-matter intake, feed-to-gain and residual feed intake.

They used the testing station for three years and in 2013 they installed their own GrowSafe feed intake system so they can test all of their yearling bulls and heifers at home.

Janssen also served as Kansas Angus Association president in 1980, served two terms as an American Angus Association director and was the 1989-90 president. He also was chairman of the Certified Angus Beef (CAB) board of directors from 1988-89.

In 2000, Richard, Shelly, Ben and Elizabeth formed a limited family partnership, and since 2010 Ben, Elizabeth and their spouses have been running the operation, with Richard and Shelly acting as advisers.

The Stockman of the Year Award is presented annually by the Livestock and Meat Industry Council.

See more here:
Genetic Engineering - Hutchinson News

Doc in St. Louis County who prescribed illegal HGH can practice … – STLtoday.com

ST. LOUIS A St. Louis County doctor who pleaded guilty last year to a federal felony, and admitted he illegally sold misbranded human growth hormone to patients, is licensed to practice medicine medicine again.

Dr. Michael Ted Mimlitz, 51, was sentenced in April 2016 to two years of probation and fined $30,000 for selling misbranded human growth hormone to local clinic patients, prosecutors said. He also had to forfeit $59,500, representing some of the proceeds from the sale of the drug.

Mimlitz went just 3 1/2 months without a medical license. The Missouri Board of Registration for the Healing Arts revoked his medical license in November. But he had already applied for a new license in October. The board granted a new license on March 2.

The license is on probation for two years. Within the first six months, he must successfully complete board-approved courses in ethics and prescribing. He could not immediately be reached for comment.

Mimlitz admitted in U.S. District Court that he become involved in the Men's Medical Institute after identifying a need for a clinic specializing in testosterone replacement therapy for men.

Patients began asking for human growth hormone, he said, and he found a Mexican supplier online after being unable to find it in the U.S. He sold the misbranded drugs to about 40 patients.

The drugs were misbranded, contained labels in Spanish, not English, and were not manufactured by a facility licensed or registered by the U.S. Food and Drug Administration, according to court testimony.

Prosecutors pointed out in a statement announcing the plea that doctors can prescribe HGH for a handful of reasons, including wasting diseases associated with AIDS or Prader-Willi syndrome, but not to help patients with body-building, anti-aging, or weight loss treatments.

Read the rest here:
Doc in St. Louis County who prescribed illegal HGH can practice ... - STLtoday.com

Citrus Ridge Health Center Now Offering New Non-Surgical Option to Facelifts, Platelet Rich Plasma Facial Treatment – P&T Community

Citrus Ridge Health Center Now Offering New Non-Surgical Option to Facelifts, Platelet Rich Plasma Facial Treatment
P&T Community
DAVENPORT, Fla., March 12, 2017 (GLOBE NEWSWIRE) -- Physical medicine and anti-aging clinic Citrus Ridge Health Center is pleased to announce they are now offering one of the hottest non-surgical options to the traditional facelift in use today.

and more »

Visit link:
Citrus Ridge Health Center Now Offering New Non-Surgical Option to Facelifts, Platelet Rich Plasma Facial Treatment - P&T Community

The First Results of Gene Editing in Normal Embryos Have Been Released – Futurism

Viable Editing

One of the most fascinating and promising developments in genetics is the CRISPR genome editing technique. Basically, CRISPR is a mechanism by which geneticists can treat disease by either disrupting genetic code by splicing in a mutation or repairing genes by splicing out mutations and replacing them with healthy code.

Researchers in China at the Third Affiliated Hospital of Guangzhou Medical University have successfully edited genetic mutations in viable human embryos for the first time. Typically, to avoid ethical concerns, researchers opt to use non-viable embryos that could not possibly develop into a child.

Previous research using these non-viable embryos has not produced promising results. The very first attempt to repair genes in any human embryos used these abnormal embryos. The study ended with abysmal results, with fewer than ten percent of cells being repaired. Another study published last year also had a low rate of success, showing that the technique still has a long way to gobefore becoming a reliablemedical tool.

However, after experiencing similar results with using the abnormal embryos again, the scientists decided to see if they would fare better with viable embryos. The team collected immature eggs from donors undergoing IVF treatment. Under normal circumstances, these cells would be discarded, as they are less likely to successfully develop. The eggs were matured and fertilized with sperm from men carrying hereditary diseases.

While the results of this round of study were not perfect, they were much more promising than the previous studies done with the non-viable embryos. The team used six embryos, three of which had the mutation that causes favism (a disease leading to red blood cell breakdown in response to certain stimuli), and the other three had the mutation that results in a blood disease called beta-thalassemia.

The researchers were able to correct two of the favism embryos. In the other, the mutation was turned off, as not all of the cells were corrected. This means that the mutation was effectively shut down, but not eliminated. It created what is called a mosaic. In the other set, the mutation was fully corrected in one of the embryos and only some cells were corrected in the other two.

These results are not perfect, but experts still do find potential in them. It does look more promising than previous papers, says Fredrik Lanner of the Karolinska Institute. However, they do understand that results from a test of only six embryos are far from definitive.

Gene editing with CRISPR truly has the possibility to revolutionize medicine. Just looking at the development in terms of disease treatment, and not the other more ethically murky possible applications, it is an extremely exciting achievement.

Not only could CRISPR help eradicate hereditarydisease, but it is also a tool that could help fight against diseases like malaria. There is a long road ahead for both the scientific and ethical aspects of the tech. Still, the possible benefits are too great to give up now.

Excerpt from:
The First Results of Gene Editing in Normal Embryos Have Been Released - Futurism

Puma Biotechnology Inc (NYSE:PBYI) Impact Score At 75 | Stock … – Stock Observer

Puma Biotechnology Inc (NYSE:PBYI) daily sentiment score is 0.103 for articles printed on 2017-03-10. This is on a -1-1 scale after assessing the buzzing news and its impact on the system. The assessment is hooked on the dependable web sources.

Bullish target is at $89 while conservative price target is $72 on respective equity.

Puma Biotechnology Inc has an ABR of 1.67. The stock rating was 1.67 in preceding quarter. Financial numbers can be released on 2017-05-09. Consensus estimated EPS is $-1.88 for this quarter.

Securities prices are motivated by fundamentals in both the controlled and open street. Informed or not, shareholders weightage is on fiscals and other allied valuation basics. The metrics under contemplation are per-share earnings and associated ratios. Investors shift their emphasis on comprehensive financial report. Also, they predict miscellaneous components, which consists the reserves and other firm resources and also its valuation to due debt. Definitely, it is an unusual exercise to assess and measure all features while generating funds in equity market. A disciplined appraisal bodes well when the notion is to contribute a fair part in planned income.

Whatever ratings Zacks gives can to some degree exhibit variance from calls of First Call. Both the entities dont poll same set of street analysts, and as a result the projections vary. Puma Biotechnology Inc (NYSE:PBYI) posted EPS of $-2.04 for period closed on 2016-12-31. The reported number was $-0.02 off from the consensus. In percentage terms variance was -0.99%.

Go here to see the original:
Puma Biotechnology Inc (NYSE:PBYI) Impact Score At 75 | Stock ... - Stock Observer

Scientists Are Close to Creating a Fully Synthetic Genome – Futurism

More Than Bread and Beer

Humans have found a friend in yeast. The single-celled eukaryotes are used by humans for a wide variety of applications, such as making alcoholic beverages and baking, among others. Scientists are heading toward a breakthrough in bioengineering that could create synthetic organisms that will help make new kinds of drugs and fuels.

An international team of researchers has been able to devise a way to synthesize a large part of yeasts genetic code. Prior to this announcement, the team had been able to completely synthesize one of yeasts 16 chromosomes. Now, the team has published a series of papers in the journal Scienceshowing that they have been able to add another five chromosomes, thus bringing their total to six. They say theyre on track to finish the remaining ten chromosomes to form a completely synthetic genome by the end of this year.

While the scientific community remains leery of synthetic genome creation, many have united in praising this projects work. In an article accompanying the research, Daniel Gibson, vice president of DNA technologies at Synthetic Genomics, stated, This is really going to allow us to understand how to design cells from the bottom up that can be reprogrammed for many applications.

Some of those many applications are what worry bioethicists, biologists, and environmentalists, among others. Todd Kuiken from North Carolina State Universitys Genetic Engineering and Society Center compares the potential accidental orpurposeful release of synthetic organisms to the introduction of invasive species. You can think of it of like introducing an invasive species into a different environment. It will have some type of impact to the system.

The yeast project is operating under conditions emphasizing safety as well as ethics. This is a whole new era where were moving beyond little edits on single genes to being able to write whatever we want throughout the genome, says George Church, a prominent Harvard University geneticist. The goal is to be able to change it as radically as our understanding permits.

See the original post:
Scientists Are Close to Creating a Fully Synthetic Genome - Futurism

Biology professor is elected a fellow of the Animal Behavior Society – Nevada Today

For more than 50 years the Animal Behavior Society has endeavored to promote the study of animal behavior on a biological level. Every year a handful of scientists who have made distinguished contributions to the study of the subject are chosen to be fellows. This year, College of Science Professor of Biology Vladimir Pravosudov was one of the few.

Pravosudov studies how small birds adapt to harsh environments. His current work focuses on chickadees, which can survive in the bleakest of wintery climates.

"They've always been of interest to me because these birds can actually live very far north, so they can survive with only a few hours of light, and then the rest is all-day sleeping," he said. "they cache a lot of food when its available in the fall, and they recover it in the winter when it could be minus 40 degrees Celsius, which is very cold. These birds use spatial memory to find these food caches, so they have amazing memories."

After comparing chickadees across a range of climates and geographies, Pravosudov has found that a chickadee's memory is adapted for its environment, and in more extreme circumstances - where food caching is necessary - the cognitive tools for memory are more developed. Providing such fascinating insight is what brought Pravosudov to the attention of his peers, and the recognition he has received has been humbling.

"Many of these people I would consider unofficial mentors," he said. "Not that I was a student with them, but I admire their work greatly, and I've read it and it helped the formation of my own ideas. This is an important society. I've been with the society for a long time and people that are a part of that group, they are very impressive."

Pravosudov received congratulations from his department chair, dean and University Provost.

"The ABS is the premier international society for scientists who study behavior," Jack Hayes, professor and biology department chair, said. "The society elected six Fellows this year, so only a very select group of highly accomplished scientists are elected. Congratulations, Vladimir on a well deserved honor."

"Professor Pravosudov is an excellent faculty member and the recognition of his scholarship by the Animal Behavior Society is well deserved," Jeff Thompson, dean of the College of Science, said. "Vladimir's research is fascinating and he mentors a large number of students that get to participate in his world class research. I am very proud to have Vladimir in the College of Science and greatly appreciate the recognition he brings to the University and the Biology Department."

Provost Kevin Carman echoed Thompson's praise, "Congratulations Vladimir, this prestigious recognition brings honor to the entire University."

While Pravosudov is happy to be recognized for the work he has done, he is also humble. He has conducted research with funding from the National Science Foundation since he began at the University in 2005, and while he believes that laurels are nice, he remains steadfastly focused on the importance of his work.

Looking to future research projects, he has submitted two pre-proposals to the National Science Foundation.

"We want to look at social networks in these birds," Pravosudov said. "We can see how these birds socialize. We can try to understand how they learn and transfer information socially. We can actually do experiments in the field, which is not very common, because traditionally cognition is studied in a lab."

Pravosudov is excited to continue his research, and his fellowship with the ABS is a cherry on top of a fulfilling career where his work is its own reward.

"I'm lucky to have spent most of my life doing what I love. I think it's a luxury. I've worked with animals and birds and I've never not been excited about something," Pravosudov said. "I think having a job like a professor at the University allows you to be like a little kid, always exposed to and learning new things, and I think that learning new things every day is the most exciting thing that I have in life.

View post:
Biology professor is elected a fellow of the Animal Behavior Society - Nevada Today

Precision Medicine Project Mulls How to Return Genetic Test Results to 1M Participants – GenomeWeb

NEW YORK (GenomeWeb) Before the National Institutes of Health can begin to genetically test participants within its precision medicine initiative, it will have to figure out what results to return, how to minimize reporting false positives, and how to provide counseling to help them navigate the often uncertain and evolving evidence on genetic information.

And the project will have to figure out how to do all this on an unprecedented scale, for a million participants that the All of Us Research Program hopes to enroll over the next four years.

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.

*Before your trial expires, well put together a custom quote with your long-term premium options.

Read the original here:
Precision Medicine Project Mulls How to Return Genetic Test Results to 1M Participants - GenomeWeb

Defensive chemistry key to Masco girls’ impressive run in tournament this year – The Daily News of Newburyport

There is no substitute for good chemistry.

Teams need just the right level of cohesion to make a big playoff run, and in the sport of hockey, successful defensive pairings need to gel in order to lock-down against the talented forwards, who are more and more explosive the deeper a team makes it into the tournament.

For the Masco girls, the two go hand-in-hand.

The Chieftains have pulled off an impressive postseason streak, winning three games en route to Mondays Division 1 state semifinal against Woburn, and one of the ingredients at the top of the list of coach Ryan Sugars formula for success is the effort and execution of his blue liners.

Our defense has a lot of great chemistry, said senior Rachael Duval, who is paired up with senior captain Madi Brooke as Mascos top tandem.Weve gotten to learn how our partners play and where the pucks are going. A huge part of defense is knowing your partner really well.

So how well do Duval and Brooke know each other?

Considering the two girls have been playing hockey together since the age of eight, there arent many things that can happen on the ice that the duo isnt prepared to handle together. It was a pass across the point from Duval to Brooke that led to one of the goals against AP, and in the shootout against Beverly, Sugar called on Brooke to take one of the five attempts and the senior lit the lamp.

The two Masconomet schoolmates were named Northeast Hockey League All-Stars with all-league honors going to Duval.

Weve literally grown up playing hockey together, Brooke said of playing with Duval. I know Rachael so well. I know everything about her game and she knows everything about me. We know each other and where were going to be.

Along with the great chemistry, preparation has been vital in terms of knowing the tendencies of opposing teams and their top forwards. Whether its who has the most dangerous shot, or where a certain forward is likely to carry the puck, Duval, Brooke and the rest of the girls on the back end know their opponents inside and out.

A big part of the strategy, according to both Sugar and Duval, is keeping the middle of the ice clean and clearing rebounds away from the crease area after freshman netminder and Newburyport student Molly Elmore makes the initial save; which is something shes done time and again during the playoffs.

Executing the game plan comes down to smarts and effort, and with seniors like Duval and Brooke, there is nothing the girls wont do to get the job done.

Especially for us seniors who have never made it this far, knowing every game could be our last 45 minutes on the ice is definitely a big motivation for us, said Brooke. All the underclassmen feel it too ... To be able to be underdogs and beat all these teams no one thought we could beat as an 18 seed is bringing us all together.

As for the other D pairing Sugar has been rolling with, Triton sophomores Riane Vatcher and Anna Behringer as well as Triton freshman Gianna Conte have been mixed and matched, and whatever grouping Sugar goes with, its been working.

The team allowed just one goal against Quincy before beating No. 2 Beverly and then holding defending state champion Austin Prep to just a goal in Tuesdays 3-1 triumph.

Rachael and Madi are probably the most dominant defensive pair in our league. Theyre both big players who can skate, move the puck and shoot, said Sugar. Riane plays on the second pair rotating in Anna and Gianna. Riane has a ton of speed and Anna and Gianna are two, solid defensemen. Those three right there are our future for the next year or two as well.

Nobody in the locker room is thinking beyond Monday evening in Woburn.

Well, that isnt entirely true. Playing in the TD Garden, which is where the state final will take place, is too alluring a prospect not to pop into the Chieftains minds.

Ivebeen talking about this with my dad for three days. Making it to a final in the Garden would be a dream come true. Every time I talk about it my cheeks get swollen and I start smiling, said Duval. It would be historical for us as a team to make it to the Garden and prove seeds are truly just numbers. And Masco girls hockey is something to talk about. I think it would be enormous for us as a program.

More here:
Defensive chemistry key to Masco girls' impressive run in tournament this year - The Daily News of Newburyport

Warriors display balance and chemistry – Pacific Daily News

Jojo Santo Tomas and Kasmira Engichy, Pacific Daily News Published 5:42 p.m. ChT March 11, 2017 | Updated 7 hours ago

Members of the St. Paul Warriors celebrate after their 63-56 win over the Father Duenas Friars to win the IIAAG Boys Basketball championship March 10 at a packed University of Guam Calvo Field House.(Photo: Kasmira Engichy/For PDN)

Around this time last year, the St. Paul Warriors were not as happy as they were Friday night.

They had just finished a dismal 5-11 season with a squad that was expected to do better, and they were relegated to the bench to watch another school win the championship they wanted.

Something clicked between the end of 2016 and start of the 2017 season for the Warriors.

They won their first game, and their second. Then then won again, and again and as the rest of the league muscled each other, it became clear they were fighting for second-best.

When the dust cleared, the Warriors finished a perfect 9-0, earning the top seed in the playoffs. They took a break from Guam basketball and visited Malaysia for a week, taking third in the Asian Christian Schools Conference tournament.

They ran to exhaustion, and they tasted defeat more than once. Yet coach Neo Pineda was only proud of them.

Back on Guam and fully recharged, the Warriors went on a mission. They blew out their first opponent by 20, then nipped their nemesis Guam High by a half-dozen points, setting up the finale.

The Warrior Machine, it seemed, was firing on full power. No hiccups like last year.

Last year, we didnt really have the chemistry and this year everything just clicked, said Jahmar White, the sophomore floor general. We just listened to our coach.

The team agreed that their chemistry off the court was valuable too, and that bodes well for the future.

White, a sophomore, said hell be back next year alongside most of his teammates, ready to defend their crown.

We will be doing the same thing as we did this year, he said. Well use what works.

See the original post:
Warriors display balance and chemistry - Pacific Daily News

More funds to flow into Department of Biotechnology’s kitty | The … – The Indian Express


The Indian Express
More funds to flow into Department of Biotechnology's kitty | The ...
The Indian Express
It's indeed a welcome move that DBT has been awarded higher amount of money this year. However, the budget is disappointing as there was no concrete plan ...

and more »

See original here:
More funds to flow into Department of Biotechnology's kitty | The ... - The Indian Express

Biology major Chiang, director of 'Smart People' at Long Wharf, won over by arts – New Haven Register

It would appear that, given the name of one of Shakespeares most recognizable female characters, director Desdemona Chiang was predestined for a life in the theater. Chiang, who directs Lydia Diamonds play Smart People, which begins performances Wednesday at Long Wharf Theatre, doesnt refute the theory when she explains that she landed in the theater by accident.

I had no intention of going into theater, said Chiang before a recent rehearsal. Desdemona is actually my given name. But I went to Berkeley for my undergrad and was a molecular and cell biology major. I had planned to go to medical school. But during my first year of college I was told by my adviser that I would have to take an arts requirement class. I thought the easiest class to take would be an intro to acting class because it didnt have a lecture, it didnt have a paper. I would just show up and play improv games the whole semester. It was the easiest A I could take.

If fate lured Chiang into a life in the theater with the prospect of an easy A, it locked her in with the promise of endearing friendships.

The theater kids were more fun to hang with than the biology kids, she said. I found myself spending more time in the theater department for completely personal and social reasons.

Advertisement

It wasnt until much later when I got into graduate school, said Chiang, who earned her MFA from the University of Washington, that I realized the value of the arts and the value of theater and all the social good and the political responsibility of doing theater.

Smart People, which officially opens March 22 and runs through April 9, is the sort of play that feeds Chiangs appetite for social good and political responsibility through dyadic interaction rather than group activism.

Im really interested in unconscious bias and implicit bias, Chiang said. This show, in a nutshell, is about four smart people who think they know how they see the world and are surprised by the ways they didnt realize that they harbor certain opinions.

These four characters Valerie (Tiffany Nichole Greene), an African-American actor fresh out of Harvards ART training program; Jackson (Sullivan Jones), an African-American surgical intern at Harvard Medical School; Brian (Peter OConnor), a Caucasian neuropsychiatrist and tenured professor at Harvard; and Ginny (Ka-Ling Cheung), a Chinese-Japanese-American tenured professor of psychology at Harvard; are four smart people who are smart, but not as smart as they think they are, as Chiang described them.

They study race, or they study culture, or they are neurosurgeons and artists, said Chiang, who was born in Taiwan and identifies as Chinese-American. So they have a perceived sense of awareness around how the world works, and how social interactions work, and how human behavior works, and yet they find themselves in these encounters where their gut impulses contradict all the right things theyre supposed to do.

Diamond, whose previous credits include Broadways Stick Fly and adapting Toni Morrisons The Bluest Eye for the stage, started writing Smart People in 2007 after reading an article by a prominent neuropsychologist studying race. It debuted in 2014 at the Huntington Theatre Company in Boston and was next produced off-Broadway just over a year ago at Second Stage.

The plays resonates more today than ever, said Chiang.

Definitely, post-2008, this play has a completely different meaning to me, she said. The play ends with the four characters watching the inauguration of our first black president. That issue is paramount now, compared to when it was produced in New York.

And, of course, the play is not a downer, she added. Its a comedy. But theres something kind of longing about it now.

The challenge to this play, Chiang said, is making these four intelligent and somewhat caustic characters human while, at the same time, honoring their wit and irony.

These are all people we have met, have seen or are related to or have relationships with, she said. These are not unfamiliar characteristics, I find.

I think that part of what Lydia has done, either consciously or unconsciously, is set up four people for us to look at as potentially stereotypical so that, over the course of the play, they become more human, Chiang said. Theyre four people we know very little about and they come off as a little bombastic and a little forward. Over the course of the play, as they interact, they catch each other; theyre surprised by each other. Some fall in love with each other, some try to fall in love and fail.

Because they start opening up to each other, she said, I think by the end of the play, hopefully, if weve laid out the series of events right, we will feel pretty much attached to and moved by them.

Chiang, who works extensively in Western regional theaters such as Oregon Shakespeare Festival, Seattle Repertory Theatre and Seattle Shakespeare Company, obviously has no regret over her choice to choose a career in the arts rather than science. She believes that she can make her mark in theater, however differently than in medicine or research.

I certainly think theres value in both areas, she said. (But) thats why I think that arts funding is the first thing to go. We dont see the immediate impact.

What we see, I feel like, in the arts is long-term, hidden impact, she said. We teach things like vulnerability. We teach leadership. And we do this by playing pretend and getting on stage and expressing ourselves and being creative. For most people, it looks recreational, which I think is a struggle.

But I will say, theater completely changed my life, Chiang said. I did not know how to have fun before I did theater. I did not know how to be vulnerable with people. I was smart, certainly, and I could write a good paper, but I couldnt stand in front of a group and speak openly and candidly about how I felt about things. Theater gave me the space and training to do that.

Read more:
Biology major Chiang, director of 'Smart People' at Long Wharf, won over by arts - New Haven Register